Lilly buys rights to novel diabetes drug
July 6, 2005Research and Development, Sales and Marketing
Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …
Antidepressants come under FDA review again
July 4, 2005Sales and Marketing
The FDA is conducting another review of antidepressants to determine whether the drugs increase the risk of suicidal behaviour in …
GSK excited about new vaccines
July 4, 2005Sales and Marketing
GlaxoSmithKline has updated investors on its vaccine pipeline, with the company expecting to launch five major vaccines within as many …
Doctors have no time to mentor nurse prescribers
June 30, 2005Doctors have expressed concern that they do not have time to act as mentors to independent nurse prescribers, according to …
The golden rules of PR
June 29, 2005Medical Communications
In light of the enormous potential brand benefits of pharma PR, the question should not be 'Shall we invest in …
Humira receives two European recommendations
June 29, 2005Sales and Marketing
Abbott's Humira has moved closer to European approval as a first-line treatment of moderate to severe early rheumatoid arthritis in …
All aboard the health train
June 29, 2005Medical Communications
Making friends and influencing people is an area, it's widely agreed, where big pharma could do better. Few companies, however, …
New products key to Schering growth
June 29, 2005Sales and Marketing
Schering has reiterated its goal of achieving an 18% operating margin in 2006 and is predicting further growth in the …
FDA approves new HIV drug Aptivus
June 29, 2005Sales and Marketing
Boehringer Ingelheim's new HIV drug Aptivus has been granted accelerated approval by the FDA. Aptivus (tipranavir) has been approved for …
GSK forms hypertension alliance
June 29, 2005Sales and Marketing
GlaxoSmithKline has formed a strategic alliance with an emerging pharma company to develop and commercialise novel compounds to treat hypertension …
FDA approves first ‘ethnic’ heart drug
June 29, 2005Research and Development, Sales and Marketing
The FDA has approved BiDil as a new treatment for heart failure in black patients, a group disproportionately affected by …
Woolley Pau wins Chiron campaign
June 29, 2005Medical Communications
Woolley Pau has been appointed by Chiron Biopharma Europe to work on a pan-European launch campaign, following a four-way pitch.A …
People Strategies launch
June 28, 2005Sales and Marketing
A new company has been launched to bring people and change management expertise to companies that are not able to …
Seven Stones expands into market research with Strata
June 28, 2005Medical Communications
Healthcare communications agency Seven Stones has launched a new market research company to be run by a former head of …
Public involvement part of Labour’s vision for primary care
June 28, 2005Health secretary Patricia Hewitt has announced plans for a major public engagement exercise to help make far-reaching changes to primary …
NHS chief executives call for an extension of patient choice
June 28, 2005An overwhelming majority of NHS chief executives believe patient choice should be extended to treatment as well as service providers, …
Roche’s Tarceva approaches EU approval
June 28, 2005Sales and Marketing
Roche's new oral cancer treatment Tarceva has received a recommendation from the EMEA's advisory committee, paving the way for its …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
